RespireRx Pharmaceuticals Inc, which is developing a dronabinol-based drug to treat obstructive sleep apnea (OSA), and ResolutionRx Ltd, an Australian subsidiary of RespireRx, have entered into a series of bilateral agreements to transfer the RespireRx pharmaceutical cannabinoid program to ResolutionRx and establish it as an operating company. “Since the incorporation of ResolutionRx at the beginning…
Avadel Pharmaceuticals plc provided a second-quarter corporate update detailing the progress following Lumryz’s approval by the US Food and Drug Administration (FDA) during the period and upcoming milestones, including seeking an expanded indication for Lumryz. The FDA approved Lumryz on May 1 as the first and only once-at-bedtime oxybate therapy for the treatment of cataplexy…
Sree Roy: Hello and welcome. I’m Sree Roy with Sleep Review, and I’m thrilled to be here with pulmonologist-sleep specialist Richard K. Bogan, MD. Dr. Bogan is a principal owner of Bogan Sleep Consultants in Columbia, South Carolina, and an experienced chief medical officer, clinician, and researcher. This episode is sponsored by Jazz Pharmaceuticals. Today,…
Audio Transcript Welcome to the Ask Pastor John podcast, especially if this is your first time here — welcome. I’m Tony, the host, and I pitch questions to longtime pastor and author John Piper. That’s his name. We talk about life’s most challenging questions, and what the Bible has to say about those challenging questions.…
New research that flips an existing therapy model will introduce a whole new way of treating obstructive sleep apnea (OSA), according to investigators of a study published in the Annals of the American Thoracic Society. Professor Danny Eckert, PhD, director at the Adelaide Institute for Sleep Health: Flinders Health and Medical Research Institute Sleep Health…
A $4 million award from the National Heart, Lung, and Blood Institute, a division of the National Institutes of Health, will allow researchers in the University of Arizona Mel and Enid Zuckerman College of Public Health to identify key factors for the successful implementation of workplace sleep coaching to improve sleep health in Arizona firefighters.Almost…
His condemnation on judgment day will punctuate the unhappiest story ever told. Never will a smile so drain of its color; never will hope shatter from such heights; never will victory retreat so ruthlessly; never will hell devour a victim so dejected and amazed as when the Almost Christian is led away to the lake…
The Therapy for Black Girls Podcast is a weekly conversation with Dr. Joy Harden Bradford, a licensed Psychologist in Atlanta, Georgia, about all things mental health, personal development, and all the small decisions we can make to become the best possible versions of ourselves. Last week we started a very important conversation to help with…
By Sree Roy Fresh off reporting its MARIPOSA Phase 2b study findings, Apnimed’s clinical development lead says the company plans to test its obstructive sleep apnea (OSA) drug candidates—AD109 (primary) and AD504 (follow-on)—in two longer clinical trials, which could ultimately lead to US Food and Drug Administration (FDA) approval of the first oral pill for…
Movements with longevity are sustained through shared, easily understood language. This most often comes through the development of axioms – short, memorable phrases that capture the essence of truth in simple ways. Reflecting on the last two decades of leading Emotionally Healthy Discipleship, I’ve been able to identify at least 10 core axioms (probably more…